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Abstract
Malarial pigment (natural haemozoin, HZ) is a ferriprotoporphyrin IX crystal produced by Plasmodium parasites after
haemoglobin catabolism. HZ-fed human monocytes are functionally compromised, releasing increased amounts of pro-
inflammatory molecules, including cytokines, chemokines and cytokine-related proteolytic enzyme Matrix Metalloprotei-
nase-9 (MMP-9), whose role in complicated malaria has been recently suggested. In a previous work HZ was shown to
induce through TNFalpha production the release of monocytic lysozyme, an enzyme stored in gelatinase granules with
MMP-9. Here, the underlying mechanisms were investigated. Results showed that HZ lipid moiety promoted early but not
late lysozyme release. HZ-dependent lysozyme induction was abrogated by anti-TNFalpha/IL-1beta/MIP-1alpha blocking
antibodies and mimicked by recombinant cytokines. Moreover, HZ early activated either p38 MAPK or NF-kappaB pathways
by inducing: p38 MAPK phosphorylation; cytosolic I-kappaBalpha phosphorylation and degradation; NF-kappaB nuclear
translocation and DNA-binding. Inhibition of both routes through selected molecules (SB203580, quercetin, artemisinin,
parthenolide) prevented HZ-dependent lysozyme release. These data suggest that HZ-triggered overproduction of
TNFalpha, IL-1beta and MIP-1alpha mediates induction of lysozyme release from human monocytes through activation of
p38 MAPK and NF-kappaB pathways, providing new evidence on mechanisms underlying the HZ-enhanced monocyte
degranulation in falciparum malaria and the potential role for lysozyme as a new affordable marker in severe malaria.
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Introduction
Malaria is one of the most common parasitic diseases in the
world and causes over 1 million deaths per year [1,2]. The
causative agent (Plasmodium) has a biological cycle in the mosquito
vector and in the human host; the most virulent among the human
malaria parasites is Plasmodium falciparum, which is responsible for
the bulk of the malaria-related morbidity and mortality [2,3].
Symptoms of uncomplicated malaria include fever, headache, and
vomiting. The major complications of severe malaria include
cerebral malaria, pulmonary edema, acute renal failure or severe
anaemia [4–7]. It mainly affects children under 5 years of age and
pregnant women, and can be fatal [8]. It is characterized by the
binding of infected red blood cell (IRBC) to the vascular
endothelium (cytoadherence) and to non-infected erythrocytes
(rosetting). The accumulation of IRBCs and non-infected RBCs
generates a reduction in the blood flow of the microvasculature,
which results in tissue hypoxia and necrosis [9]. There is growing
evidence that the combination of both parasite and host factors is
involved in the pathogenesis of severe malaria. Among parasite
products, natural haemozoin (HZ, malaria pigment) may be a
candidate. HZ is a lipid-bound ferriprotoporphyrin IX crystal
produced by late stages (trophozoites and schizonts) of Plasmodium
parasites, and is avidly phagocytosed by human phagocytic cells
such as monocytes and macrophages [10]. As a result of
phagocytosis, several functions of monocytes are seriously com-
promised, including repeated phagocytosis [11], bacterial killing
abilities [12], oxidative burst [11], MHC Class II expression and
antigen presentation [13], maturation to dendritic cells [14], and
coordination of erythropoiesis [15]. However, impaired HZ-laden
human monocytes do not undergo apoptosis: apparently, HZ-
dependent enhanced expression of anti-apoptotic HSP-27 leads to
prolonged monocyte survival, thereby contributing to maintain the
impaired monocytes in the bloodstream [16,17]. Moreover, HZ-
fed monocytes show enhanced gene expression of a large number
of pro-inflammatory molecules, including cytokines (TNFalpha,
IL-1beta, IL-1RA) and chemokines (MIP-1alpha and beta,
GROalpha, beta and gamma, MCP-1, IL-8, ENA-78) [16]. HZ
also upregulates expression and activity of few monocytic enzymes.
As more extensively reviewed by Prato and Giribaldi [18], HZ was
shown in a series of recent works from our group to increase
RNA/protein expression, protein release and proteolytic activity
of matrix metalloproteinase-9 (MMP-9), a cytokine-related pro-
teolytic enzyme. Additionally, in a recent study we showed that
2 h after phagocytosis, HZ promoted production and release of
high amounts of lysozyme [19], an antibacterial protein defined by
its ability to hydrolyse beta-1,4-glycosidic linkage between N-
acetylmuramic acid and N-acetylglucosamine of peptidoglycan in
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the cell wall of bacteria (muramidase activity) [20]. This finding
appears particularly relevant in the context of research for early
diagnosis markers of severe malaria, since plasma lysozyme levels
in malaria patients have been related to disease severity [21,22];
additionally, it should be coupled with the ground-breaking
evidence recently published by Kajla et al. showing that in
Anopheles vectors the mosquito lysozyme homologue facilitates the
development of Plasmodium berghei and falciparum through direct
binding to parasite oocysts [23]. In the present work, the
mechanisms underlying HZ-dependent human lysozyme enhance-
ment in monocytes were investigated, focusing on the dependence
on production of pro-inflammatory molecules and activation of
p38 mitogen-activated protein kinase (MAPK) and nuclear factor-
kappaB (NF-kappaB) pathways.
Materials and Methods
Materials
Unless otherwise stated, reagents were obtained from Sigma-
Aldrich, St. Louis, MO. Sterile plastics were from Costar, Cam-
bridge, UK; Cell culture media RPMI, TRIzol, M-MLV, oligo-dT,
sense and anti-sense primers, Platinum Taq DNA Polymerase were
from Invitrogen, Carlsbad, CA; Panserin 601 monocyte medium
was from PAN Biotech, Aidenbach, Germany; Percoll was from
Pharmacia, Uppsala, Sweden; Diff-Quik parasite stain was from
Baxter Dade AG, Dudingen, Switzerland; enzyme-linked immuno-
adsorbent assay (ELISA) kits for TNFalpha and IL-1beta assay were
from Cayman, Ann Arbor, MI; blocking anti-hTNFalpha/IL-1beta
antibodies and rhTNFalpha/IL-1beta were from Merck, Darm-
stadt, Germany; ELISA kits for MIP-1alpha, anti-hMIP-1alpha
blocking antibodies and rhMIP-1alpha were from R&D Systems,
Minneapolis, MN; p38 MAPK inhibitor SB203580 was from Cell
Signaling Technology, Danvers, MA; bicinchoninic acid protein
assay was from Pierce, Rockford, IL; anti-I-kappaBalpha and anti-
NF-kappaB-p65 polyclonal antibodies and anti-P-p38 MAPK, anti-
p38 MAPK, anti-P-I-kappaBalpha and anti-NF-kappaB-p50 mono-
clonal antibodies were from Santa Cruz Biotechnology, Santa Cruz,
CA; electrophoresis reagents were from Bio-Rad Laboratories,
Hercules, CA; DNA-free kit was from Ambion, Austin, TX; Beacon
Designer 7.0 software was from Premier Biosoft International, Palo
Alto, CA; dNTPs were from Applied Biosystem, Foster City, CA.
Culturing of P. Falciparum and Isolation of HZ
P. falciparum parasites (Palo Alto strain, mycoplasma-free) were
kept in culture as described [24,25]. To isolate HZ, IRBCs (4–8%
parasitemia) were washed twice with serum-free culture medium,
re-suspended to 25% haematocrit and fractionated on a discon-
tinuous Percoll/6% mannitol (wt/vol) gradient (0, 40, 80%); after
centrifugation at 1075g, HZ was collected at the top of the 0–40%
gradient interphase, extensively washed with (hypotonic) 10 mM
phosphate buffer (pH 8.0) containing 10 mM mannitol and stored
at 220uC; repeated washings with 10 mM hypotonic PBS of the
isolated HZ was done to lyse eventual residual contaminating cells
and remove cell remnants [26]. The haem content of a weighed
amount of HZ dissolved in 0.1 M NaOH was determined by
reading the absorbance at 385 nm (6.16104 M cm21, Soret
band). Beta-haematin (sHZ, synthetic HZ) was prepared in
methanol as previously described [24]. For delipidized HZ
(dHZ), lipid extraction was performed as previously reported [24].
Preparation and Handling of Monocytes
Human monocytes were separated by Ficoll centrifugation from
freshly collected buffy coats discarded from blood donations by
healthy adult donors of both sexes provided by the local blood
bank (AVIS, Associazione Volontari Italiani Sangue, Torino,
Italy); informed consent from donors was obtained by AVIS, and
human specimens were further handled anonymously by our
group [27]. Separated lympho/monocytes were re-suspended in
RPMI 1640 medium and plated on wells of 6-well plates. Each
well received 2 ml of cell suspension containing 86106 cells/ml in
RPMI 1640. The plates were incubated in a humidified CO2/air-
incubator at 37uC for 60 min. Thereafter non-adherent cells were
removed by 3 washes with RPMI 1640 and adherent cells re-
incubated at 37uC overnight in RPMI 1640. Shortly before
starting phagocytosis, wells were washed with RPMI 1640 and
Panserin 601 medium was added (2 ml/well).
Pre-Selection of NF-KappaB-Quiescent Monocytes by
Flow Cytometry and Real Time RT-PCR
Before starting experiments, a pre-selection of cell populations
was taken as a precautionary measure, as previously described
[27]. Briefly, cell cultures isolated through Ficoll separation were
analyzed by flow cytometry. Only cell populations showing at least
70% monocytes were used for following experiments. Additionally,
in order to avoid the use of NF-kappaB pre-activated monocytes,
cells were analyzed by Real Time RT-PCR: in each cell
preparation a cell aliquot was stimulated or not with LPS (1 mg/
ml) for 4 h, and TNFalpha RNA production was measured in
lysates by Real Time RT-PCR. GAPDH was used as house-
keeping gene. Only unstimulated monocyte populations (‘‘NF-
kappaB-quiescent’’ cells) showing at least a 3-PCR-cycles gap of
cDNA amplification between controls and LPS-stimulated cells
were used for subsequent experiments.
Phagocytosis of Opsonized Latex Particles or HZ and
Treatment with Recombinant Cytokines, Blocking
Antibodies and Chemical Inhibitors
Latex particles and HZ washed once and finely dispersed at
30% (v/v) in PBS were added to the same volume of fresh human
AB serum (AVIS blood bank) and incubated for 30 min at 37uC to
reach opsonization as described [27]. Phagocytosis was started by
adding to adherent monocytes opsonized latex particles, HZ, sHZ
or dHZ (50 RBC equivalents, in terms of haem content, per
monocyte). The plates were then incubated in Panserin 601
medium in a humidified CO2/air-incubator at 37uC for 2 h. After
the end of the phagocytic period, cells were checked by optical
microscopy: as an average, HZ-containing monocytes were 25–
35% among the total cells, a percentage compatible with in vivo
levels measured in patients with severe malaria showing high
parasitaemia [28]. Therefore, monocytes were washed and
incubated in Panserin 601 medium in a humidified CO2/air-
incubator at 37uC for the indicated times in the presence/absence
of: anti-hTNFalpha, anti-hIL-1beta, or anti-hMIP-1alpha block-
ing antibodies (all 30 ng/ml); rhTNFalpha, rhIL-1beta, or rhMIP-
1alpha (all 20 ng/ml); p38 MAPK inhibitor SB203580, quercetin,
artemisinin or parthenolide (all 10 microM except quercetin:
15 microM).
Assay of Lysozyme Activity
Lysozyme released from adherent monocytes was assayed as
previously described [19]. Briefly, monocyte supernatants were
incubated with suspensions of Mycrococcus Lysodeikticus at an
OD450nm of 1 in 0.4 M phosphate buffered saline, pH 6.7, at
37uC. The change in OD450nm was measured after 30 min
incubation. A standard calibration curve was generated with
purified chicken egg lysozyme. One enzyme unit of enzyme
Mechanisms of Haemozoin-Induced Lysozyme Release
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activity corresponded to a decrease of 0.001 OD units each
minute.
Assay of TNFalpha, IL-1beta, and MIP-1alpha Production
The levels of soluble TNFalpha, IL-1beta, and MIP-1alpha
were assayed in monocyte supernatants by specific ELISA. A
standard calibration curve was generated with rhTNF, rhIL-1beta,
and rhMIP-1alpha, according to the manufacturer’s instructions.
Isolation of Cytosolic and Nuclear Protein Fractions in
Cell Lysates
Cells were mechanically scraped in PBS and washed, then
resuspended in lysis buffer (15 mM KCl, 10 mM HEPES, 2 mM
MgCl2, 0.1 mM EDTA, 1 mM PMSF, 1 mM DTT, 10 mg/ml
aprotinin, 2 mg/ml leupeptin, 0.1% NP-40, pH 7.6). Cell suspen-
sions were then incubated for 15 min on ice with occasional
vortexing, and centrifuged for 30 s to pellet nuclei. Supernatants
with cytosolic proteins were collected for following experiments.
Nuclei were rinsed with wash buffer (2 mM KCl, 25 mM HEPES,
0.1 mM EDTA, 1 mM PMSF, 1 mM DTT, 10 mg/ml aprotinin,
2 mg/ml leupeptin, pH 7.6) and incubated at 4uC for 20 min.
Nuclear extracts were then prepared by centrifugation at 20,000g
for 15 min in lysis buffer (25 mM HEPES, 0.1 mM EDTA, 20%
glycerol, pH 7.6) and used for subsequent experiments. Protein
concentration was determined using a bicinchoninic acid assay.
Assay of p38 MAPK, P-p38 MAPK, I-KappaBalpha, P-I-
KappaBalpha, p50(NF-KappaB) and p65(NF-KappaB)
Protein Levels by Western Blotting (WB)
Nuclear or cytosolic proteins were separated on 10 or 12%
polyacrylamide gel, blotted on polyvinylidene difluoride mem-
brane, and probed with different primary antibodies: polyclonal
anti-I-kappaBalpha, anti-NF-kappaB-p65 and anti-actin antibod-
ies, or monoclonal anti-P-p38 MAPK, anti-p38 MAPK, anti-P-I-
kappaBalpha and anti-NF-kappaB-p50 antibodies. After staining
with secondary anti-rabbit or anti-mouse horse-radish peroxidase-
conjugated antibodies, bands were visualized by ECL staining.
Every blot was re-used for multiple times by stripping and re-
staining. Firstly, all blots were analyzed for actin protein levels
(housekeeping gene, data not shown), in order to verify that equal
protein amounts were present in each lane. Therefore, all blots
were stripped, and grouped in three separate batches. Every batch
was used twice, to analyze two different proteins: the first batch
was used to study both p38 MAPK and P-p38 MAPK proteins;
the second one was used for P-I-kappaBalpha and I-kappaBalpha
proteins; and the third one for NF-kappaB-p65 and NF-kappaB-
p50 proteins.
Assay of NF-KappaB Complex Nuclear Translocation by
Electrophoretic Mobility Shift Assay (EMSA)
Probes containing the NF-kappaB oligonucleotide consensus
sequence were labelled with 32P (3,000 Ci/mmol, 250 mCi) using
T4 polinucleotide kinase. Nuclear extracts were incubated for
20 min with 20,000 cpm of 32P-labeled double-stranded oligonu-
cleotide at 4uC in a reaction mixture containing 10 mg/ml BSA,
10x buffer (100 mM KCl, 20 mM HEPES, 0.5 mM EDTA,
2 mM DTT, 0.1 PMSF, 20% glycerol, 0.25% NP-40, pH 7.6), 5x
buffer (300 mM KCl, 100 mM HEPES, 10 mM DTT, 100 mM
PMSF, 20% Ficoll, pH 7.6) and 1 mg/ml poly(dI-dC). The DNA-
protein complex was separated on a non denaturing 4%
polyacrylamide gel. After electrophoresis, the gel was dried and
autoradiographed by overnight exposure to X-ray film.
Statistical Analysis
For each set of experiments, data are shown as means + SEM
(lysozyme assay and ELISA) or as a representative image (WB and
EMSA) of three independent experiments with similar results. All
data were analyzed by a one-way Analysis of Variance (ANOVA)
followed by Tukey’s post-hoc test (software: SPSS 16.0 for
Windows, SPSS Inc., Chicago, IL).
Results
The Lipid Moiety of HZ Promotes Early Time-Dependent
Release of Lysozyme from Human Adherent Monocytes
In a previous work, we showed that HZ induced lysozyme
release from human monocytes 2 h after the end of phagocytosis
[19]. In order to clarify whether a time-dependence of this effect
occurred, and to identify what component of HZ among ferric and
lipid moieties was responsible, human adherent monocytes were
unfed (control cells, CTR) or fed with HZ, sHZ and dHZ for 2 h.
After termination of phagocytosis cells were washed and incubated
for 48 additional h. Cell supernatants were collected 0, 1, 2, 24
and 48 h after the end of phagocytosis, and lysozyme activity levels
were measured by a specific spectrometric assay. Results are
shown in Figure 1. CTR cells released basal levels of lysozyme
(>6000 and>9000 activity units at 1st and 2nd h, respectively, and
>25000 activity units at both 24th and 48th h). After phagocytosis
of HZ, lysozyme levels in cell supernatants were almost double
than those released from CTR cells after 1 and 2 h (p,0.0001); on
the contrary, no significant differences between CTR and HZ
were observed at longer incubation times. Moreover, phagocytosis
of lipid-free HZ (sHZ and dHZ) did not reproduce HZ effects, and
lysozyme levels in cell supernatants were similar to those of unfed
cells at all times of the observational period.
Role of Pro-Inflammatory Molecules TNFalpha, IL-1beta,
and MIP-1alpha in HZ-Dependent Early Induction of
Lysozyme Release from Human Adherent Monocytes
HZ-induced lysozyme release from human monocytes was
previously shown to be partially dependent on HZ-enhanced
TNFalpha production [19]. Thus, the possible role for two
additional HZ-enhanced pro-inflammatory molecules (IL-1beta
and MIP-1alpha) as soluble mediators of early lysozyme release
was investigated, in order to verify whether they could synergise
with TNFalpha. Human adherent monocytes were unfed (CTR
cells), fed with latex particles (control meals, latex-fed cells), or
fed with HZ (HZ-fed cells) for 2 h. After termination of
phagocytosis cells were washed and incubated for 2 additional
h. Cell supernatants were collected every 30 min up to 2 h after
the end of phagocytosis, and TNFalpha, IL-1beta, and MIP-
1alpha production was measured by ELISA, as a preliminary
assessment of protein levels. Results are shown in Figure 2. CTR
(Panel A) and latex-fed (Panel B) cells released time-dependently
low levels of all the pro-inflammatory molecules studied, with less
than 100 pg/ml for TNFalpha and less than 30 pg/ml for either
IL-1beta or MIP-1alpha at the latter time-point evaluated in
both conditions. After phagocytosis of HZ (Panel C, HZ-fed
cells), the time-dependent production of IL-1beta was signifi-
cantly higher than CTR/latex-fed cells, reaching up to 150 pg/
ml at the latter time-point evaluated (p,0.0001). TNFalpha and
MIP-1alpha production in HZ-fed cells was not significantly
different than CTR/latex-fed cells at the earlier time-points
measured, whereas it became significantly higher during the
observational period, reaching up to 500 pg/ml for TNFalpha
(p,0.0001) and up to 150 pg/ml for MIP-1alpha (p,0.0001) at
Mechanisms of Haemozoin-Induced Lysozyme Release
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the latter time-point evaluated. Further experiments were
performed to investigate and compare the role of pro-inflamma-
tory molecules IL-1beta, MIP-1alpha, and TNFalpha (alone or
combined) in the HZ-dependent early induction of lysozyme
release from monocytes. Two different approaches were adopted:
in the first one, CTR/HZ-fed cells were incubated for 2 h either
with a single dose (20 ng/ml) of rhTNFalpha, rhIL-1beta and
rhMIP-1alpha or with a combination of them (mimicking
approach); alternatively, cells were incubated for 2 h either with
a single dose (30 ng/ml) of anti-hTNFalpha, anti-hIL-1beta or
anti-hMIP-1alpha blocking antibodies or with a combination of
them (blocking approach). Thereafter, the levels of lysozyme
activity were measured in monocyte supernatants by spectromet-
ric assay. Results are shown in Figure 3 (Panel A: mimicking
approach; Panel B: blocking approach). The levels of lysozyme
released from unfed cells and HZ-fed cells should be referred as
negative and positive controls, respectively; additionally, the
values obtained by using rhTNFalpha or anti-TNFalpha
antibodies (already published previously in [19]) serve as internal
controls between single and combined treatments. As shown in
Panel A, the effect of HZ was partially mimicked by the addition
of single doses of rhTNFalpha (p,0.01), rhIL-1beta (p,0.01),
and rhMIP-1alpha (p,0.05) to unfed cells, whereas a totally HZ-
mimicking effect was reached by adding a full combination of all
recombinant cytokines (p,0.0001). None of treatments with
recombinant cytokines did affect basal lysozyme release from
HZ-fed cells (p not significant). As shown in Panel B, the effect of
HZ on lysozyme release was reduced by the addition of single
doses of anti-hTNFalpha (p,0.0001), anti-hIL-1beta (p,0.0001),
and anti-hMIP-1alpha (p,0.0001) blocking antibodies and
totally abrogated by adding a full combination of all blocking
antibodies to HZ-fed cells (p,0.0001). None of treatments with
blocking antibodies did affect basal lysozyme release from unfed
cells (p not significant).
Involvement of p38 MAPK Pathway in HZ-Dependent
Early Induction of Lysozyme Release from Human
Adherent Monocytes
Human adherent monocytes were unfed or fed with HZ for 2 h
and then incubated for 2 additional h in the presence/absence of p38
MAPK inhibitor SB203580 (10 microM). Therefore, p38 MAPK
protein expression and phosphorylation were evaluated by WB in
cell lysates, whereas lysozyme release was measured by spectromet-
ric assay in cell supernatants. Results are shown in Figure 4 (panel A:
p38 MAPK phosphorylation; panel B: p38 MAPK expression; Panel
C: lysozyme release). None of treatments did affect the basal levels of
p38 MAPK. Phosphorylation of p38 MAPK protein was not
observed in unstimulated monocytes, whereas it was induced after
phagocytosis of HZ; as expected, SB203580 prevented HZ-
dependent p38 MAPK phosphorylation, without affecting unfed
cells. Moreover, the HZ-dependent early induction of lysozyme
release (p,0.0001) was abrogated by p38 MAPK inhibitor
(p,0.0001), which did not affect basal lysozyme levels of unfed
cells (p not significant).
Involvement of NF-KappaB Pathway in HZ-Dependent
Early Induction of Lysozyme Release from Human
Adherent Monocytes
Human adherent monocytes were unfed or fed with HZ for 2 h
and then incubated for 2 additional h in the presence/absence of
three molecules which have been reported to block NF-kappaB
signaling at different levels: 15 microM quercetin, inhibitor of I-
kappaBalpha phosphorylation and subsequent degradation [29];
10 microM artemisinin, inhibitor of NF-kappaB nuclear translo-
cation [30]; and 10 microM parthenolide, inhibitor of NF-kappaB
binding to DNA [31]. Therefore, cell supernatants were collected
and cytosolic and nuclear fractions were isolated from cell lysates.
Cytosolic I-kappaBalpha protein phosphorylation and degrada-
tion, along with nuclear translocation of p65 and p50 NF-kappaB
Figure 1. Early time-dependent induction of lysozyme release from HZ-fed human adherent monocytes: role of the lipid moiety of
HZ. Cells were unfed (control cells, CTR) and fed with HZ, sHZ or dHZ for 2 h; then, lysozyme levels in cell supernatants were monitored 0, 1, 2, 24 and
48 h after the end of phagocytosis by spectrometric assay. Data are means + SEM of three independent experiments. Lysozyme release from
monocytes is indicated as enzyme activity units measured in a 2 ml-well of cell supernatants. All data were evaluated for significance by ANOVA. Vs
CTR *p,0.0001; Vs HZ up,0.0001.
doi:10.1371/journal.pone.0039497.g001
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Figure 2. Early time-dependent enhanced production of TNFalpha, IL-1beta, and MIP-1alpha by HZ-fed human adherent
monocytes. Cells were unfed (CTR cells) (Panel A), fed with latex particles (latex-fed cells) (Panel B), or fed with HZ (HZ-fed cells) (Panel C) for 2 h;
afterwards, production of TNFalpha, IL-1beta, and MIP-1alpha was monitored every 30 min in cell supernatants up to 2 h. Data are means + SEM of
three independent experiments. Production of pro-inflammatory molecules is indicated as pg/ml. All data were evaluated for significance by ANOVA.
HZ-fed vs CTR cells: *p,0.0001 for TNFalpha (120 min); up,0.01 for IL-1beta (60 min), uup,0.0001 for IL-1beta (90 and 120 min); 1p,0.001 for MIP-
1alpha (60 min), 11p,0.0001 for MIP-1alpha (90 and 120 min).
doi:10.1371/journal.pone.0039497.g002
Mechanisms of Haemozoin-Induced Lysozyme Release
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39497
subunits were evaluated by WB; nuclear DNA/NF-kappaB
complex binding was evaluated by EMSA; lysozyme release into
supernatants was measured by spectrometric assay. Results are
shown in Figure 5. Phosphorylation (Panel A) and degradation
(Panel B) of I-kappaBalpha protein were not observed in
unstimulated monocytes, while they were suddenly induced after
phagocytosis of HZ. Quercetin prevented HZ-dependent I-
kappaBalpha phosphorylation and degradation, without affecting
unfed cells. P65 (Panel D) and p50 (Panel E), two NF-kappaB
subunits, were not found in the nuclear fraction of unstimulated
cell lysates, while they showed up after phagocytosis of HZ.
Artemisinin prevented HZ-dependent p65 and p50 NF-kappaB
nuclear translocation, without affecting unfed cells. Binding of NF-
kappaB complex to DNA (Panel G) was absent in unstimulated
monocytes, while it was promoted by phagocytosis of HZ.
Parthenolide prevented HZ-dependent NF-kappaB/DNA bind-
ing, without affecting unfed cells. The HZ-dependent early
induction of lysozyme release (p,0.0001) was abrogated by all
NF-kappaB inhibitors (p,0.0001), which did not affect basal
lysozyme levels of unfed cells (Panels C, F, H; p not significant).
Discussion
Three major distinct lysozyme types showing high level of
homology have been identified in the animal kingdom: c-type
(chicken-type), present in several members of the Chordata,
including humans, and different classes of the Arthropoda,
including mosquitoes; g-type (goose-type), in few members of the
Chordata and in some bivalve mollusks; and i-type (invertebrate-
tipe), in the Invertebrates [20]. Human lysozyme was the first
mammalian lysozyme to be sequenced and served as a model
protein for a wide variety of studies [32]. In the recent years, little
evidence on the involvement of lysozymes in malaria pathogenesis
has emerged from few studies in Anopheles mosquito vector and
human host. In Anopheles gambiae, stephensi, and dirus, lysozyme was
shown to bind to oocysts of Plasmodium berghei and falciparum and
therefore facilitate their development within the mosquito [23,33].
In humans, plasma levels of lysozyme, along with those of
mieloperoxidase and lipocalin, correlated significantly to degree of
parasitaemia, suggesting that the levels of these molecules might be
good markers of severe malaria [21,22]. Moreover, in a recent
work published by our group, higher levels of lysozyme were found
in supernatants of human monocytes 2 h after phagocytosis of HZ,
the malarial pigment produced by Plasmodium parasites after
haemoglobin catabolism [19]. The present work was conceived
and expanded upon this evidence, focusing on mechanisms
underlying HZ-dependent induction of lysozyme release.
Preliminar analysis was consistent with our previous results [19],
as HZ promoted in a time-dependent manner early lysozyme
release (1–2 h after the end of phagocytosis). However, lysozyme
release was not increased at later time-points (24–48 h), when a
plateau was achieved, possibly as a result of monocyte complete
degranulation. Collectively, these time course experiments suggest
Figure 3. Role of TNFalpha, IL-1beta and MIP-1alpha in HZ-dependent induction of lysozyme release from human monocytes. Cells
were unfed (negative controls) or fed with HZ (positive controls) for 2 h. Afterwards, cells were incubated for 2 h alone and with a single dose (20 ng/
ml) or a combination of rhTNFalpha, rhIL-1beta and rhMIP-1alpha (Panel A, mimicking approach); alternatively, cells were incubated for 2 h alone and
with a single dose (30 ng/ml) or a combination of anti-hTNFalpha, anti-hIL-1beta or anti-hMIP-1alpha blocking antibodies (Panel B, blocking
approach). Thereafter, lysozyme release was measured by spectrometric assay. Data are means + SEM of three independent experiments. Lysozyme
release from monocytes is indicated as enzyme activity units measured in a 2 ml-well of cell supernatants. All data were evaluated for significance by
ANOVA. Panel A: Vs unstimulated cells (column 1) *p,0.05, **p,0.01, ***p,0.0001; Vs untreated HZ-fed cells (column 2) up,0.05, uup,0.01. Panel B:
Vs unstimulated cells (column 1) *p,0.0001; Vs untreated HZ-fed cells (column 2) up,0.0001.
doi:10.1371/journal.pone.0039497.g003
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that HZ induces a very rapid response, and apparently a second
wave of lysozyme release is not likely to occur.
Further investigation was aimed at determining what compo-
nent of HZ could be responsible for early lysozyme induction. HZ
has a scaffold structure composed either by the ferric haem or the
lipid moiety, which contains large amounts of mostly esterified
monohydroxy derivatives (OH-PUFAs: hydoxy-octadecadienoic
acids, HODEs; and hydoxy-eicosatetraenoic acids, HETEs), the
stable end products of peroxidation of polyenoic fatty acids,
generated through non-enzymatic haem-catalysis; the concentra-
tions of OH-PUFA are approximately 90 micromoles per liter
RBC equivalents: 13- and 9-HODE and 9-, 12-, and 15-HETE
are predominant in HZ, and the estimated concentrations of all
HETE isomers are 39 micromoles per liter RBC equivalents [26].
In the present work, lipid-free sHZ and dHZ did not reproduce
the effects of HZ on lysozyme early release, suggesting a major role
for the lipid moiety of HZ. Nevertheless, it has been recently
proposed that the phagocytosis of the packaging digestive vacuole -
and not only of HZ released after schizogony - might be at the root
of pathway activation in phagocytic cells [34]. Thus, at the
moment an in vivo involvement of the full digestive vacuole as a
causative agent of the enhanced lysozyme levels found in plasma of
patients with malaria [21,22] cannot be excluded.
As a following goal, the possible soluble mediators for HZ-
dependent lysozyme early release were searched. In our previous
study, the involvement of TNFalpha was proposed; however, a
likely role for other not yet identified pro-inflammatory molecules
was also speculated, as the upregulatory effects of HZ on lysozyme
release were only partially mimicked by exogenous recombinant
TNFalpha or abrogated by blocking antibodies [19]. Notable, in
human phagocytes such as neutrophil granulocytes and monocytes
lysozyme is stored, among others, in the so-called gelatinase
granules, which also contain MMP-9 [35]. In a series of previous
works, we showed that HZ enhances expression, release and
activity of human constitutive monocytic MMP-9 [18] but not
inducible MMP-2 [36], and that such an enhancement appears to
be mediated by several pro-inflammatory molecules, including
TNFalpha [37], IL-1beta [38], and MIP-1alpha [39]. The gene
expression of these molecules, along with that of other cytokines
and chemokines, was previously reported to be upregulated by
HZ, and praecox IL-1beta production was suggested to trigger the
expression of all other genes [16]. This evidence is strengthened by
the data from this work, showing early HZ-enhanced protein
release of IL-1beta, TNFalpha and MIP-1alpha; interestingly, HZ-
dependent enhancement of IL-1beta and MIP-1alpha production
was already significant 1 h after the end of phagocytosis, whereas a
significant TNFalpha increase was found only at the latter time-
point (120 min).
Moreover, as resulting from experiments with blocking
antibodies and recombinant cytokines, IL-1beta and MIP-1alpha
appeared to be causally connected to the HZ-dependent induction
of lysozyme release, in a manner similar to TNFalpha. Indeed
anti-IL-1beta and MIP-1alpha blocking antibodies reduced,
although did not fully abrogate, the HZ-dependent induction of
lysozyme release; on the other hand, recombinant IL-1beta and
MIP-1alpha partially mimicked the effects of HZ, promoting
lysozyme release without reaching the HZ-induced levels. Appar-
ently, all three molecules are required as soluble mediators to fulfil
HZ-dependent lysozyme upregulation, since the combination of
exogenous TNFalpha, IL-1beta and MIP-1alpha induced lyso-
zyme levels similar to those induced by HZ, while mixed anti-
TNFalpha, anti-IL-1beta and anti-MIP-1alpha abrogated HZ-
induced lysozyme release. These data are consistent with previous
documents showing lysozyme gene dependence on cytokine levels
[40,41].
Nevertheless, it should be critical to underline that, contrary to
lysozyme, HZ-dependent enhanced production of TNFalpha, IL-
1beta and MIP-1alpha appears to be continuous and to go on also
at longer times, as demonstrated by previous works from our
group: for instance, 25 ng/ml TNFalpha were measured in HZ-
fed monocyte supernatants 72 h after phagocytosis [37]; 35 ng/ml
IL-1beta 48 h after phagocytosis [38]; and 20 ng/ml MIP-1alpha
24 h after phagocytosis [39]. Meanwhile, it should be taken in
account that HZ-fed monocytes produce increased amounts of
several chemotactic molecules other than MIP-1alpha (that is
MIP-1beta, GROalpha, GRObeta, GROgamma, MCP-1, IL-8,
and ENA-78) [16], and show compromised ability to perform
repeated phagocytosis [11]. Thus, in order to translate the present
findings into acute and chronic human malaria, and to explain the
higher plasma levels of lysozyme found in patients with malaria
[21,22] it is reasonable to hypothesize that the lysozyme
accumulation might be a consequence of two complementary
events: on the one hand, immediately after HZ phagocytosis
human monocytes may release higher amounts of lysozyme; on
the other hand, after full release of lysozyme, HZ-laden monocytes
could go on producing pro-inflammatory molecules, such as
TNFalpha, IL-1beta, MIP-1alpha as well as other chemokines,
Figure 4. Involvement of p38 MAPK pathway in HZ-dependent
induction of lysozyme release from human adherent mono-
cytes. Cells were unfed (negative controls) or fed with HZ (positive
controls) for 2 h; after phagocytosis, cells were incubated for 2 h alone
and with 10 microM p38 MAPK synthetic inhibitor SB203580. Therefore,
p38 MAPK protein expression and phosphorylation was evaluated by
WB in cell lysates (Panels A and B), whereas lysozyme release was
measured by spectrometric assay in cell supernatants (Panel C). Results
are shown as a representative blot (A–B) or means + SEM (C) of three
independent experiments. Lysozyme release from monocytes is
indicated as enzyme activity units measured in a 2 ml-well of cell
supernatants. In lysozyme release studies, data were also evaluated for
significance by ANOVA. Vs unstimulated cells (column 1) *p,0.0001; Vs
untreated HZ-fed cells (column 2) up,0.0001.
doi:10.1371/journal.pone.0039497.g004
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which might in turn recruit other monocytes into the areas of
parasite sequester in microvessels. Therefore, as a consequence of
increased circulating levels of TNFalpha, IL-1beta, and MIP-
1alpha, and as a result of additional phagocytosis of HZ by newly
recruited monocytes (but not of repeated phagocytosis by those
already laden), new lysozyme release would be induced, thus
contributing to enhance total lysozyme circulating levels.
As a next step, the mechanisms of signal transduction
underlying HZ-dependent lysozyme enhancement were investi-
gated. To date, the pathways activated by HZ in human
monocytes have been scarcely described so far, although some
helpful information comes from several murine models. According
to few in vitro and in vivo studies, an involvement of MAPK in
malaria appears to be likely. In murine macrophages or
monocytes, HZ was shown to induce activation of p38 [42], and
ERK1/2 [43–45], but not JNK-2/STAT-1 [43,44] pathways,
whereas Plasmodium falciparum glycosylphosphatidylinositol (PfGPI)
promoted phosphorylation of all routes [46,47]. Interestingly,
inhibition of PfGPI-dependent activation of MAPK decreased
inflammatory responses and enhanced phagocytic clearance of
IRBC in mice infected by Plasmodium berghei or chabaudi chabaudi
[48]. In human monocytes, the effects of HZ on MAPK regulation
have not been described yet; however, Lucchi et al. recently
reported in syncytiotrophoblast cells a HZ-dependent phosphor-
ylation of ERK1/2 and an IRBC-dependent phosphorylation of
JNK-1; both events were causally related to production of pro-
inflammatory molecules (TNFalpha, MIP-1alpha, IL-8) [49,50].
The present study shows for the first time that HZ activates p38
MAPK pathway in human monocytes, by inducing p38 MAPK
phosphorylation without altering basal protein levels. Such an
event is directly connected to HZ-induced lysozyme levels, as
demonstrated by experiments using a specific synthetic inhibitor of
p38 signalling (SB203580), which abrogated the effects of HZ on
lysozyme activity in monocyte supernatants. These observations
are consistent with previous data correlating activation of MAPK
pathways to degranulation from human neutrophils [51] and p38
MAPK phosphorylation to lysozyme release in vibrio-infected
mussel granulocytes [52].
In addition, c-lysozyme gene has been reported to be regulated
also through NF-kappaB signaling [53]. Interestingly, little
evidence on HZ-dependent NF-kappaB activation is presently
available: in human monocytes, HZ was shown to upregulate
in vitro MMP-9 through long-term (24h after phagocytosis) I-
kappaBalpha degradation and NF-kappaB nuclear translocation
[27,54], whereas in murine macrophages either HZ or sHZ
promoted cytokine/chemokine production through NF-kappaB
activation in vitro and in vivo [43–45]. In the present work an
early activation of NF-kappaB pathway in human monocytes was
found 2 h after phagocytosis of HZ, which induced cytosolic I-
kappaBalpha phosphorylation and degradation, p50/p65 NF-
kappaB subunits nuclear translocation and NF-kappaB/DNA
binding. All these effects of HZ were abrogated by quercetin,
artemisinin, and parthenolide, three molecules which have been
reported as NF-kappaB inhibitors [29–31] and showing antima-
larial properties [55,56]. Moreover, quercetin, artemisinin, and
parthenolide inhibited the HZ-dependent enhancement of
Figure 5. Involvement of NF-kappaB pathway in HZ-dependent induction of lysozyme release from human adherent monocytes.
Cells were unfed (negative controls) or fed with HZ (positive controls) for 2 h; after phagocytosis, cells were incubated for 2 h alone and with: 15
microM quercetin, an inhibitor of cytosolic I-kappaBalpha protein phosphorylation (Panels A–C); 10 microM artemisinin, an inhibitor of p65 and p50
NF-kappaB subunits nuclear translocation (Panels D–F); and 10 microM parthenolide, an inhibitor of DNA/NF-kappaB complex binding (Panels G–H).
Therefore, I-kappaBalpha protein phosphorylation (A) and degradation (B), along with p65 (D) and p50 (E) nuclear translocation were evaluated by
WB in cytosolic and nuclear fractions of cell lysates, respectively; DNA/NF-kappaB complex binding (G) was evaluated by EMSA in nuclear fraction of
cell lysates; and lysozyme release was measured by spectrometric assay in cell supernatants (C, F, H). Results are shown as representative images (WB
and EMSA studies) or means + SEM (lysozyme release studies) of three independent experiments. Lysozyme release from monocytes is indicated as
enzyme activity units measured in a 2 ml-well of cell supernatants. In lysozyme release studies, data were also evaluated for significance by ANOVA.
Panel C: Vs unstimulated cells (column 1) *p,0.0001; Vs untreated HZ-fed cells (column 2) up,0.0001. Panel F: Vs unstimulated cells (column 1)
*p,0.0001; Vs untreated HZ-fed cells (column 2) up,0.0001. Panel H: Vs unstimulated cells (column 1) *p,0.0001; Vs untreated HZ-fed cells (column
2) up,0.0001.
doi:10.1371/journal.pone.0039497.g005
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lysozyme levels in monocyte supernatants, suggesting a potential
role for NF-kappaB in lysozyme regulation by HZ. Interestingly,
in a previous work these three inhibitors abrogated the
upregulating effects of HZ on MMP-9, TNF and IL-1beta
production by human monocytes [27].
In conclusion, the present study shows that phagocytosis of HZ
promotes an early cytokine/chemokine-mediated lysozyme release
from human monocytes through early activation of p38 MAPK
and NF-kappaB pathways. Since the lipid moiety of HZ appears to
be involved in lysozyme early release, future studies should be
aimed at investigating what lipids might be responsible for such an
induction. Interestingly, the lipid moiety of HZ was previously
shown to induce TNFalpha, IL-1beta and MMP-9, but not MIP-
1alpha, and a major role for 15-HETE was speculated [16,38,57].
Moreover, the interaction between IL-1 and HETEs was
associated with activation of NF-kappaB and MAPK pathways
[58]. Thus, a role for 15-HETE could be likely also in HZ-induced
lysozyme release. Collectively, the findings of the present work
support the hypothesis suggesting a potential role for lysozyme as
an early marker of disease severity in falciparum malaria, and might
be useful in order to design in the future specific diagnostic
approaches for severe malaria.
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